TORONTO, ON / ACCESSWIRE / January 7, 2025 / ProteinQure, a leader in computational peptide design, is proud to announce the addition of two distinguished leaders to its team. Dr. Dave Garman has been ...

TORONTO, ON / ACCESSWIRE / / ProteinQure, a leader in computational peptide design, is proud to announce the addition of two ...

New in vivo preclinical data announced today, demonstrate that icovamenib, in combination with semaglutide showed additional 11.5% body weight ...

Understanding the connection between hormones and neurological health is essential for managing conditions like migraines. Discover how mood, emotional regulation, hormonal triggers and more can play ...

Dr. Yeilding received options to purchase 38,520 shares and restricted stock units (RSUs) to acquire 31,779 shares of Protagonist Therapeutics common stock. The exercise price of the options is $38.98 ...

KEEN to lose weight in 2025? So are almost half of our readers. While weight-loss jabs, similar to Ozempic, boomed in ...

In the ever-evolving field of modern medicine, biomarker testing has emerged as a critical tool for understanding the ...

SCO-240 is under clinical development by Scohia Pharma and currently in Phase I for Growth Hormone Deficiency.

Ghrelin, known as the 'hunger hormone', also increases when caloric intake is reduced, signalling the brain to stimulate ...

From barrier creams and peptides gaining popularity for reducing fine lines, to sunscreen being reimagined in several ways ...

These weight management drugs, which mimic natural hormones that regulate insulin and glucose levels, have become increasingly popular due to their effectiveness in promoting weight loss. However, ...

How does exercise benefit health? Molecules called exerkines partly regulate its effects and provide therapeutic targets to ...